Mortality attributable to tobacco among men in Sweden and other European countries: an analysis of data in a WHO report
Lars Ramström 1  
More details
Hide details
Institute for Tobacco Studies, Täby, Sweden
Liqusa Research, Åtvidaberg, Sweden
Lars Ramström   

Institute for Tobacco Studies, Kanalvägen 17, 18338 Täby, Sweden
Publication date: 2014-09-01
Tobacco Induced Diseases 2014;12(September):14
It is well known that Swedish men have lower tobacco-related mortality than men in other European countries, but there are questions that need further investigation to what extent this is related to the specific patterns of tobacco use in Sweden, where use of snus, the Swedish low-nitrosamine oral tobacco, dominates over smoking in men but not in women. The recent WHO Global Report: Mortality Attributable to Tobacco provides a unique set of estimates of the health burden of tobacco in all countries of the world in the year 2004, and these data can help elucidating the above-mentioned questions.

For Sweden and all other European Union Member States mortality data for a number of tobacco-related causes of death were extracted from the WHO Report. The size of the mortality advantage for selected causes of death in different age groups of Swedish men compared to men of the same age in Europe as a whole was calculated in terms of ratios of death rates attributable to tobacco. Differences between age groups with respect to tobacco-related mortality were analyzed with respect to differences in terms of development and status of smoking and snus use. The analyses also paid attention to differences between countries regarding tobacco control regulations.

Among men in the European Union Member States the lowest level of mortality attributable to tobacco was consistently found in Sweden, while Swedish women showed levels similar to European average. A strong co-variation was found between the mortality advantage and the degree of dominance of snus use in the different age groups of Swedish men. Among Swedish women there are no age groups with dominant use of snus, and similar observations were therefore not possible for women.

The above findings support the assumption that the widespread use of snus instead of cigarettes among Swedish men may be a major part of the explanation behind their position with Europe’s lowest mortality attributable to tobacco.

Zatoński W, Przewoźniak K, Sulkowska U, West R, Wojtyła A: Tobacco smoking in countries of the European Union. Ann Agric Environ Med. 2012, 19 (2): 181-192.
World Health Organization: WHO Global Report: Mortality Attributable to Tobacco. 2012, Geneva, Available from: accessed on 07/08/14.
Statistics Sweden: Use of alcohol and tobacco. Report no 114, Living Conditions. 2007, Stockholm, Available from: accessed on 07/08/14.
Joossens L, Raw M: The Tobacco Control Scale 2010 in Europe. 2011, Brussels: Association of European Cancer Leagues, Available from: http://www.europeancancerleagu....
Foulds J, Ramström L, Burke M, Fagerström K: Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003, 12: 349-359. 10.1136/tc.12.4.349.
Engholm G, Ferlay J, Christensen N, Johannesen TB, Khan S, Køtlum JE, Milter MC, Olafsdóttir E, Pukkala E, Storm HH: NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 6.1 (25.04.2014). Association of the Nordic Cancer Registries. Danish Cancer Society, Available from: accessed on 07/08/14.
Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, Sweanor D, Warner KE: The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev. 2004, 13: 2035-2042.
Gartner CE, Hall WH, Vos TH, Bertram MY, Wallace AL, Lim SS: Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet. 2007, 369: 2010-2014. 10.1016/S0140-6736(07)60677-1.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): Harm reduction: evidence, impacts and challenges. EMCDDA scientific monograph No.10. 2010, Lisbon: EMCDDA.
Ramström LM, Foulds J: Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control. 2006, 15: 210-214. 10.1136/tc.2005.014969.
Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, Sullivan PF: Is Swedish snus associated with smoking initiation or smoking cessation?. Tob Control. 2005, 14: 422-424. 10.1136/tc.2005.012476.
Galanti MR, Rosendahl I, Wickholm S: The development of tobacco use in adolescence among “snus starters” and “cigarette starters”: An analysis of the Swedish “BROMS” cohort. Nicotine Tob Res. 2008, 10: 315-323. 10.1080/14622200701825858.
Stenbeck M, Hagquist C, Rosén M: The association of snus and smoking behaviour: a cohort analysis of Swedish males in the 1990s. Addiction. 2009, 104: 1579-1585. 10.1111/j.1360-0443.2009.02661.x.
Foulds J, Kozlowski L: Snus — what should the public-health response be?. Lancet. 2007, 369: 1976-1978. 10.1016/S0140-6736(07)60679-5.
Perceived Health Risks of Snus and Medicinal Nicotine Products
Dorothy K. Hatsukami, R. I. Vogel, Herb H. Severson, Joni A. Jensen, Richard J. O’Connor
Nicotine & Tobacco Research
The Case for Requiring Graphic Warning Labels on Smokeless Tobacco Product Packages
Smita Pakhale, Jonathan Samet, Patricia Folan, Frank Leone, Alexander White
Annals of the American Thoracic Society
Interventions to reduce harm from continued tobacco use
Nicola Lindson-Hawley, Jamie Hartmann-Boyce, Thomas R Fanshawe, Rachna Begh, Amanda Farley, Tim Lancaster
Cochrane Database of Systematic Reviews
Patterns of Smoking and Snus Use in Sweden: Implications for Public Health
Lars Ramström, Ron Borland, Tom Wikmans
International Journal of Environmental Research and Public Health
Analytical Assessment of E-Cigarettes
K.E. Farsalinos
Carbonyl Emissions in E-cigarette Aerosol: A Systematic Review and Methodological Considerations
Konstantinos E. Farsalinos, Gene Gillman
Frontiers in Physiology
Electronic cigarettes: an aid in smoking cessation, or a new health hazard?
Konstantinos Farsalinos
Therapeutic Advances in Respiratory Disease
Does reduced smoking if you can’t stop make any difference?
Rachna Begh, Nicola Lindson-Hawley, Paul Aveyard
BMC Medicine
Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching
Dorothy K Hatsukami, Herbert Severson, Amanda Anderson, Rachael Isaksson Vogel, Joni Jensen, Berry Broadbent, Sharon E Murphy, Steven Carmella, Stephen S Hecht
Tobacco Control
E-cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation
Kenneth E Warner, David Mendez
Nicotine & Tobacco Research
Is smoking a risk factor for lumbar disc herniation?
Weimin Huang, Ying Qian, Kai Zheng, Lili Yu, Xiuchun Yu
European Spine Journal
Differential Taxes for Differential Risks — Toward Reduced Harm from Nicotine-Yielding Products
Frank J. Chaloupka, David Sweanor, Kenneth E. Warner
New England Journal of Medicine
Potential gains in life expectancy by reducing inequality of lifespans in Denmark: an international comparison and cause-of-death analysis
José Manuel Aburto, Maarten Wensink, Alyson van Raalte, Rune Lindahl-Jacobsen
BMC Public Health
How to Think—Not Feel—about Tobacco Harm Reduction
Kenneth E Warner
Nicotine & Tobacco Research
The Relationship Between Handball Players and Alcohol and Smoking Habits
Hrvoje Karnincic, Marijana Cavala, Nenad Rogulj
Journal of Human Kinetics
Determination of thermal degradants in e-cigarette fluid via direct sample introduction (DSI) gas chromatography-tandem mass spectrometry
Kevin J. Bisceglia, Sahar Caravan, Keegan Rogers, Ling Huang
Analytical Methods
Much safer with snus
L. Ramström
Kenneth Warner
Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers
R. Icick, S. Gard, M. Barde, M. Carminati, A. Desage, S. Guillaume, J. Scott, F. Bellivier
Journal of Affective Disorders
Smokeless Tobacco Products
Nicotine vaping products as a harm reduction tool among smokers: Review of evidence and implications for pharmacy practice
Daniel Erku, Coral Gartner, Kylie Morphett, Centaine Snoswell, Kathryn Steadman
Research in Social and Administrative Pharmacy
CrossTalk proposal: The benefits of e‐cigarettes outweigh the harms
Rachna Begh, Paul Aveyard
The Journal of Physiology